申请人:——
公开号:US20030236295A1
公开(公告)日:2003-12-25
Having an affinity against serotonine receptors, compound (I) shown below is useful as a therapeutic agent against various kinds of diseases of central nervous systems.
1
(wherein R
1
is hydrogen; R
2
is hydrogen or lower alkyl; R
3
is hydrogen, —COOR
12
and so on; R
4
is hydrogen, lower alkyl and so on, or R
3
and R
4
taken together may form ═O or ═S; R
5
is hydrogen, or R
3
and R
5
taken together may form a bond; R
6
is hydrogen, —COOR
24
and so on; R
7
is hydrogen, halogen, lower alkyl and so on; R
8
is hydrogen, lower alkyl, cycloalkyl and so on; R
9
, R
10
and R
11
are each independently hydrogen, halogen, lower alkyl and so on)
针对5-羟色胺受体具有亲和力的化合物(I),如下所示,可用作治疗中枢神经系统各种疾病的治疗剂。其中R1为氢;R2为氢或较低的烷基;R3为氢,—COOR12等;R4为氢,较低的烷基等,或者R3和R4一起可能形成═O或═S;R5为氢,或者R3和R5一起可能形成键;R6为氢,—COOR24等;R7为氢,卤素,较低的烷基等;R8为氢,较低的烷基,环烷基等;R9、R10和R11各自独立地为氢,卤素,较低的烷基等。